Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at ceralasertib for ovarian and endometrial clear cell cancers (ATARI)

Overview

Cancer types:

Cervical cancer, Ovarian cancer, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with certain subtypes of gynaecological cancers that have come back after treatment. It is open to people with ovarian or endometrial clear cell cancers and certain types of other rare gynaecological cancers particularly endometrioid, carcinosarcoma or cervical cancers.

You pronounce ceralasertib as se-ra-la-sir-tib.

Cancer Research UK supports this trial.

Recruitment start: 25 November 2019

Recruitment end: 31 January 2026

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Susana Banerjee

Supported by

AstraZeneca

Cancer Research UK

Institute of Cancer Research (ICR)

Lady Garden Foundation

Other information

This is Cancer Research UK trial number is CRUKE/18/014.

Last reviewed: 30 Jan 2026

CRUK internal database number: 16452

Help and support